Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 49 articles:
HTML format

Single Articles

    April 2023
    Balancing the benefits and harms of cervical cancer screening in older women.
    Cancer. 2023;129:979-980.

    March 2023
  2. FOSTER KI, Shaw KRM, Jin J, Westin SN, et al
    Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
    Cancer. 2023 Mar 17. doi: 10.1002/cncr.34724.
    PubMed     Abstract available

  3. METCALFE KA, Gronwald J, Tung NM, McCuaig JM, et al
    The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
    Cancer. 2023;129:901-907.
    PubMed     Abstract available

  4. CHINO JP, Moss HA, Swartz JJ, Gray BA, et al
    Care of the pregnant patient with cancer should include unfettered access to abortion.
    Cancer. 2023 Mar 12. doi: 10.1002/cncr.34686.

  5. NGUYEN T, Bhosale PR, Cassia L, Surabhi V, et al
    Malignancy in pregnancy: Multimodality imaging and treatment.
    Cancer. 2023 Mar 12. doi: 10.1002/cncr.34688.
    PubMed     Abstract available

  6. HENDRIKSE CSE, van der Ploeg P, van de Kruis NMA, Wilting JHC, et al
    Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma.
    Cancer. 2023 Mar 3. doi: 10.1002/cncr.34661.
    PubMed     Abstract available

  7. GRISHAM RN, Manning-Geist BL, Chui MH
    Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
    Cancer. 2023 Mar 3. doi: 10.1002/cncr.34658.

    FDA grants accelerated approval for targeted therapy for platinum-resistant gynecologic cancers.
    Cancer. 2023;129:656.

    February 2023
  9. HYDE ET, LaCroix AZ, Evenson KR, Howard AG, et al
    Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
    Cancer. 2023 Feb 22. doi: 10.1002/cncr.34699.
    PubMed     Abstract available

    January 2023
  10. BEN-ARYE E, Segev Y, Galil G, Marom I, et al
    Acupuncture during gynecological oncology surgery: A randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety.
    Cancer. 2023 Jan 17. doi: 10.1002/cncr.34542.
    PubMed     Abstract available

  11. PODWIKA SE, Duska LR
    Top advances of the year: Cervical cancer.
    Cancer. 2023 Jan 7. doi: 10.1002/cncr.34617.
    PubMed     Abstract available

    December 2022
  12. KANG EY, Weir A, Meagher NS, Farrington K, et al
    CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
    Cancer. 2022 Dec 26. doi: 10.1002/cncr.34582.
    PubMed     Abstract available

    October 2022
  13. LUTGENDORF SK, Thaker PH, Goodheart MJ, Arevalo JMG, et al
    Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression.
    Cancer. 2022 Oct 17. doi: 10.1002/cncr.34496.
    PubMed     Abstract available

  14. DUSKA LR
    Overcoming disparities to improve cancer care: The story of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34488.
    PubMed     Abstract available

  15. VIKRAMAN SM, Khanna D, Dandpat A
    Cervical cancer elimination in indian context: Moving from barriers to facilitators.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34486.
    PubMed     Abstract available

  16. RIMEL BJ, Kunos CA, Macioce N, Temkin SM, et al
    Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34487.
    PubMed     Abstract available

  17. MARKOVINA S, Rendle KA, Cohen AC, Kuroki LM, et al
    Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34485.
    PubMed     Abstract available

  18. O'ROURKE K
    First person profile: Robert C. Bast Jr MD: As an ovarian cancer expert, Dr Bast has made history by identifying cancer antigen 125, and he has shared his knowledge by mentoring the next generation of physicians: As an ovarian cancer expert, Dr Bast h
    Cancer. 2022;128:3431-3432.

    August 2022
  19. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed     Abstract available

    July 2022
  20. MOUKARZEL LA, Ferrando L, Stylianou A, Lobaugh S, et al
    Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer.
    Cancer. 2022 Jul 6. doi: 10.1002/cncr.34356.
    PubMed     Abstract available

    June 2022
  21. RAUH-HAIN JA, Zubizarreta J, Nitecki R, Melamed A, et al
    Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
    Cancer. 2022 Jun 29. doi: 10.1002/cncr.34371.
    PubMed     Abstract available

  22. MARTH C, Abreu MH, Andersen KK, Aro KM, et al
    Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
    Cancer. 2022 Jun 17. doi: 10.1002/cncr.34350.
    PubMed     Abstract available

  23. JAMIESON A, Barroilhet LM, McAlpine JN
    Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
    Cancer. 2022 Jun 3. doi: 10.1002/cncr.34328.
    PubMed     Abstract available

  24. O'ROURKE K
    Cemiplimab shines for recurrent cervical cancer.
    Cancer. 2022;128:2050-2051.

  25. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available

    May 2022
  26. NERO C, Pasciuto T, Cappuccio S, Corrado G, et al
    Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
    Cancer. 2022 May 26. doi: 10.1002/cncr.34331.
    PubMed     Abstract available

  27. STENZEL AE, Bustamante G, Sarkin CA, Harripersaud K, et al
    The intersection of sexual orientation with race and ethnicity in cervical cancer screening.
    Cancer. 2022 May 16. doi: 10.1002/cncr.34213.
    PubMed     Abstract available

  28. O'ROURKE K
    Pembrolizumab is effective for endometrial cancer.
    Cancer. 2022;128:1886-1887.

    April 2022
  29. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.

    February 2022
  30. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available

  31. LU E, Hatchell KE, Nielsen SM, Esplin ED, et al
    Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.
    Cancer. 2022;128:675-684.
    PubMed     Abstract available

    January 2022
  32. HENDERSON TO, Fowler BW, Hamann HA, Nathan PC, et al
    Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Cancer. 2022;128:373-382.
    PubMed     Abstract available

  33. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available

    December 2021
  34. MCBRIDE CM, Pathak S, Johnson CE, Alberg AJ, et al
    Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.
    Cancer. 2021 Dec 9. doi: 10.1002/cncr.34053.
    PubMed     Abstract available

  35. BELLONE S, Roque DM, Siegel ER, Buza N, et al
    A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34025.
    PubMed     Abstract available

  36. ANTILL Y, Buchanan DD, Scott CL
    Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34024.
    PubMed     Abstract available

  37. MOMTAZ P, O'Connor CA, Chou JF, Capanu M, et al
    Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
    Cancer. 2021;127:4393-4402.
    PubMed     Abstract available

    November 2021
  38. PEI J, Li M, Wu C, Xu M, et al
    Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34029.

  39. LIN S, Gao K, Jin M
    Reply to Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34031.

  40. TEMKIN SM, Smeltzer MP, Dawkins MD, Boehmer LM, et al
    Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.
    Cancer. 2021 Nov 17. doi: 10.1002/cncr.34023.
    PubMed     Abstract available

  41. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed     Abstract available

    October 2021
  42. DIN HN, Strong D, Singh-Carlson S, Corliss HL, et al
    Association between pregnancy intention and preconception health behaviors.
    Cancer. 2021 Oct 11. doi: 10.1002/cncr.33958.
    PubMed     Abstract available

  43. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.

    Rucaparib is a safe and effective maintenance therapy for advanced pancreatic cancer.
    Cancer. 2021;127:3498.

  45. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available

    September 2021
  46. KOTSOPOULOS J, Kim SJ, Armel S, Bordeleau L, et al
    An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
    Cancer. 2021;127:3183-3193.
    PubMed     Abstract available

    August 2021
  47. SCHAEFER IM, Lundberg MZ, Demicco EG, Przybyl J, et al
    Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
    Cancer. 2021;127:2666-2673.
    PubMed     Abstract available

    June 2021
  48. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available

    March 2021
  49. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.